Report Detail
Global Irinotecan Market Insights, Forecast to 2025
- RnM2670586 |
- 08 March, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The global Irinotecan market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Irinotecan market based on company, product type, end user and key regions.
This report studies the global market size of Irinotecan in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irinotecan in these regions.
This research report categorizes the global Irinotecan market by top players/brands, region, type and end user. This report also studies the global Irinotecan market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
West-Ward Pharmaceuticals
Pfizer
Teva
Actiza Pharmaceutical
Getwell
Taj Pharma
Cipla
Salius
Market size by Product
Irinotecan Hydrochloride Injection 40mg
Irinotecan Hydrochloride Injection 100mg
Other
Market size by End User
Colon cancer
Rectal cancer
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Irinotecan market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Irinotecan market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Irinotecan companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Irinotecan submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Irinotecan are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irinotecan market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Irinotecan Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Irinotecan Market Size Growth Rate by Product
- 1.4.2 Irinotecan Hydrochloride Injection 40mg
- 1.4.3 Irinotecan Hydrochloride Injection 100mg
- 1.4.4 Other
- 1.5 Market by End User
- 1.5.1 Global Irinotecan Market Size Growth Rate by End User
- 1.5.2 Colon cancer
- 1.5.3 Rectal cancer
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Irinotecan Market Size
- 2.1.1 Global Irinotecan Revenue 2014-2025
- 2.1.2 Global Irinotecan Sales 2014-2025
- 2.2 Irinotecan Growth Rate by Regions
- 2.2.1 Global Irinotecan Sales by Regions
- 2.2.2 Global Irinotecan Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Irinotecan Sales by Manufacturers
- 3.1.1 Irinotecan Sales by Manufacturers
- 3.1.2 Irinotecan Sales Market Share by Manufacturers
- 3.1.3 Global Irinotecan Market Concentration Ratio (CR5 and HHI)
- 3.2 Irinotecan Revenue by Manufacturers
- 3.2.1 Irinotecan Revenue by Manufacturers (2014-2019)
- 3.2.2 Irinotecan Revenue Share by Manufacturers (2014-2019)
- 3.3 Irinotecan Price by Manufacturers
- 3.4 Irinotecan Manufacturing Base Distribution, Product Types
- 3.4.1 Irinotecan Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Irinotecan Product Type
- 3.4.3 Date of International Manufacturers Enter into Irinotecan Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Irinotecan Sales by Product
- 4.2 Global Irinotecan Revenue by Product
- 4.3 Irinotecan Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Irinotecan Breakdown Data by End User
6 North America
- 6.1 North America Irinotecan by Countries
- 6.1.1 North America Irinotecan Sales by Countries
- 6.1.2 North America Irinotecan Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Irinotecan by Product
- 6.3 North America Irinotecan by End User
7 Europe
- 7.1 Europe Irinotecan by Countries
- 7.1.1 Europe Irinotecan Sales by Countries
- 7.1.2 Europe Irinotecan Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Irinotecan by Product
- 7.3 Europe Irinotecan by End User
8 Asia Pacific
- 8.1 Asia Pacific Irinotecan by Countries
- 8.1.1 Asia Pacific Irinotecan Sales by Countries
- 8.1.2 Asia Pacific Irinotecan Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Irinotecan by Product
- 8.3 Asia Pacific Irinotecan by End User
9 Central & South America
- 9.1 Central & South America Irinotecan by Countries
- 9.1.1 Central & South America Irinotecan Sales by Countries
- 9.1.2 Central & South America Irinotecan Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Irinotecan by Product
- 9.3 Central & South America Irinotecan by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Irinotecan by Countries
- 10.1.1 Middle East and Africa Irinotecan Sales by Countries
- 10.1.2 Middle East and Africa Irinotecan Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Irinotecan by Product
- 10.3 Middle East and Africa Irinotecan by End User
11 Company Profiles
- 11.1 West-Ward Pharmaceuticals
- 11.1.1 West-Ward Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 West-Ward Pharmaceuticals Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 West-Ward Pharmaceuticals Irinotecan Products Offered
- 11.1.5 West-Ward Pharmaceuticals Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Irinotecan Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Teva
- 11.3.1 Teva Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Irinotecan Products Offered
- 11.3.5 Teva Recent Development
- 11.4 Actiza Pharmaceutical
- 11.4.1 Actiza Pharmaceutical Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Actiza Pharmaceutical Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Actiza Pharmaceutical Irinotecan Products Offered
- 11.4.5 Actiza Pharmaceutical Recent Development
- 11.5 Getwell
- 11.5.1 Getwell Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Getwell Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Getwell Irinotecan Products Offered
- 11.5.5 Getwell Recent Development
- 11.6 Taj Pharma
- 11.6.1 Taj Pharma Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Taj Pharma Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Taj Pharma Irinotecan Products Offered
- 11.6.5 Taj Pharma Recent Development
- 11.7 Cipla
- 11.7.1 Cipla Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Cipla Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Cipla Irinotecan Products Offered
- 11.7.5 Cipla Recent Development
- 11.8 Salius
- 11.8.1 Salius Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Salius Irinotecan Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Salius Irinotecan Products Offered
- 11.8.5 Salius Recent Development
12 Future Forecast
- 12.1 Irinotecan Market Forecast by Regions
- 12.1.1 Global Irinotecan Sales Forecast by Regions 2019-2025
- 12.1.2 Global Irinotecan Revenue Forecast by Regions 2019-2025
- 12.2 Irinotecan Market Forecast by Product
- 12.2.1 Global Irinotecan Sales Forecast by Product 2019-2025
- 12.2.2 Global Irinotecan Revenue Forecast by Product 2019-2025
- 12.3 Irinotecan Market Forecast by End User
- 12.4 North America Irinotecan Forecast
- 12.5 Europe Irinotecan Forecast
- 12.6 Asia Pacific Irinotecan Forecast
- 12.7 Central & South America Irinotecan Forecast
- 12.8 Middle East and Africa Irinotecan Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Irinotecan Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Irinotecan . Industry analysis & Market Report on Irinotecan is a syndicated market report, published as Global Irinotecan Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Irinotecan market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
